4Wiviott SD,Antman EM. Clopidogrel resistance:a new chapter in a fast-moving story[J]. Circulation,2004,9(13) :3064-3067.
5Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting : response variability, drug resistance, and the effect of pre- treatment platelet reactivity [ J ]. Circulation, 2003, 107 ( 23 ) : 2908 -2913.
6Laurent B, Laurence CJ. Adjusted clopidogrel loading doses ac- cording to vasodilator-stimulated phosphoprotein phosphorylationindex decrease rate of major adverse cardiovascular events in pa- tients with clopidogrel resistance. Am Coli Cardiol,2008,51 ( 14 ) : 1404-1411.
7Fontana P, Dupont A, Gandrille S, et al. Adenosine diphosphate- induced platelet aggregation is associated with P2Y12 gene se- quence varations in healthy subjects [ J ]. Circulation, 2003,108 (8) :989-995.
8Ziegler S, Sehillinger M, Funk M,et al. Association of a functional polymorphism in the clopidogrel target receptor gene. P2Y12. and the risk for is chemic cerebrovascular events in patients with pe-ripheral artery disease [ J ]. Stroke,2005,36 ( 11 ) : 1395-1397.
9Jamie SJE,Bernard DW,Swami VK,et al.Monitoring heparin therapy:APTT results from partial-vs full-draw tubes[J].American Journal of Clinical Pathology,1998,110(2):184～187.
